In Brief: Boston Scientific breather
This article was originally published in The Gray Sheet
Boston Scientific breather: Firm ends shopping spree and plans to "take a breath for a little while" on the merger and acquisition front, company Chairman and CEO Pete Nicholas tells investors at the Piper Jaffray medical device conference. The minimally invasive devices firm has entered seven merger agreements since August 1994, making deals for: Cardiovascular Imaging Systems, Scimed, Heart Technology, EP Technologies, Meadox Medical, Vesica Medical, and Symbiosis...
You may also be interested in...
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.